Tianbo Xu
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Oncology
- Immunology
- Topics
- Ferroptosis and cancer prognosis (13 papers)Renal cell carcinoma treatment (9 papers)Epigenetics and DNA Methylation (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaClinical Cancer ResearchExperimental Cell Research
In The Last Decade
Tianbo Xu
27 papers receiving 722 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 512
- Pulmonary and Respiratory Medicine 324
- Cancer Research 305
- Oncology 112
- Immunology 70
Countries citing papers authored by Tianbo Xu
This map shows the geographic impact of Tianbo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianbo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianbo Xu more than expected).
Fields of papers citing papers by Tianbo Xu
This network shows the impact of papers produced by Tianbo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianbo Xu. The network helps show where Tianbo Xu may publish in the future.
Co-authorship network of co-authors of Tianbo Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Tianbo Xu. A scholar is included among the top collaborators of Tianbo Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianbo Xu. Tianbo Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 8 | |
| 3 | 7 | |
| 4 | 20 | |
| 5 | 5 | |
| 6 | 52 | |
| 7 | 20 | |
| 8 | 19 | |
| 9 | 10 | |
| 10 | 20 | |
| 11 | 24 | |
| 12 | 90 | |
| 13 | 45 | |
| 14 | 31 | |
| 15 | 25 | |
| 16 | 26 | |
| 17 | 18 | |
| 18 | 36 | |
| 19 | 33 | |
| 20 | 64 |
About Tianbo Xu
Tianbo Xu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 27 papers that have together received 728 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (13 papers), Renal cell carcinoma treatment (9 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (305 citations), Pulmonary and Respiratory Medicine (324 citations) and Molecular Biology (512 citations). Tianbo Xu has collaborated with scholars based in China and France. Frequent co-authors include Xiaoping Zhang, Hongmei Yang, Hailong Ruan, Di Liu, Ke Chen, Lin Bao, Jingchong Liu, Yuenan Liu, Keshan Wang and Qi Cao. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.